New hope for kids with tough neuroblastoma: targeted radiation trial shows promise

NCT ID NCT03966651

Completed Disease control Sponsor: Institut Claudius Regaud Source: ClinicalTrials.gov ↗

First seen Nov 18, 2025 · Last updated Jun 15, 2026 · Updated 28 times

Summary

This early-phase study tested a targeted radiation therapy (PRRT) in children whose neuroblastoma had come back or not responded to standard treatments. The therapy uses a radioactive drug that seeks out cancer cells. The main goal was to find the safest dose. Only one child took part, and the study is now complete.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

CHU Angers

Angers, France
CHU Besançon

Besançon, France
CHU Dijon

Dijon, France
CHU Nancy

Nancy, France
CHU Nantes

Nantes, France
CHU Pellegrin

Bordeaux, France
CHU Reims

Reims, France
CHU Strasbourg

Strasbourg, France
CHU de Grenoble

Grenoble, France
CHU de Toulouse - Hôpital des enfants

Toulouse, France
Centre Léon Bérard

Lyon, France
Centre Oscar Lambret

Lille, France
Hopital Arnaud de Villeneuve

Montpellier, France
IUCT-O

Toulouse, France

Conditions

Explore the condition pages connected to this study.

NEUROBLASTOMA NEUROBLASTOMA